Matrix Metalloproteinase-9/Gelatinase B is a Putative Therapeutic Target of Chronic Obstructive Pulmonary Disease and Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|9|1|34-46

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.9, Iss.1, 2008-02, pp. : 34-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylase pathway: an evolving therapeutic target in chronic obstructive pulmonary disease

By Antoniu Sabina A  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 329-332

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of gelatinase B (matrix metalloproteinase-9) by dihydrolipoic acid

By Cantin André M   Martel Marc   Drouin Geneviève   Paquette Benoit  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 3, 2005-03 ,pp. : 301-308

NRC Research Press

Access to resources Recommend Favorite

Nitric Oxide Synthase (NOS) as Therapeutic Target for Asthma and Chronic Obstructive Pulmonary Disease

By  

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 721-735

Bentham Science Publishers

Access to resources Recommend Favorite

NF-#954;B, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 6, 2008-12 ,pp. : 536-557

Bentham Science Publishers

Access to resources Recommend Favorite

Bronchial Asthma, Chronic Obstructive Pulmonary Disease and NF-&kgr;B

By  

Current Medicinal Chemistry, Vol. 16, Iss. 7, 2009-03 ,pp. : 867-883

Bentham Science Publishers

Access to resources Recommend Favorite